Kadmos Capital: Investment Portfolio & Startup News
Kadmos Capital
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
InTouchNow raises a £2.3m seed round led by Ada Ventures to handle inbound patient calls for NHS GP practices
InTouchNow is a UK-based AI voice agent for NHS general practice that answers inbound patient calls 24 hours a day. The system handles appointment booking, triage data collection and routine administrative tasks, passing clinical and more complex queries to practice staff.
Big Picture Bio raises a £1.5m pre-seed round led by Kadmos Capital and Exceptional Ventures to design cancer combination therapies
Big Picture Bio identifies, designs and optimises cancer combination therapies using a generative world model of how tumours, immune cells and surrounding tissue interact across disease sites and patient subgroups. Pairing that modelling with targeted wet-lab validation, the platform selects drug combinations and sequencing intended to minimise residual disease in cancer and immune-mediated diseases.
OutSee completes its £2.5m seed round led by Ahren Innovation Capital for its genomic drug discovery platform
OutSee develops AI-driven genomics software that identifies disease targets directly from genetic data, supporting drug discovery by uncovering biological mechanisms missed by conventional analysis methods.
Scindo lands £4m in funding from Kadmos Capital and Clay Capital to develop enzyme platform for sustainable chemicals
Scindo develops an AI-driven enzyme design platform that enables sustainable production of bio-based chemicals and ingredients from renewable feedstocks across multiple industries.
OutSee raises £1.8m seed round led by Ahren Innovation Capital to advance AI-driven genomic target discovery
OutSee builds a predictive genomics platform that uses hypothesis-free AI modelling to discover new therapeutic targets, supporting precision medicine across neurological, rare and metabolic diseases.
Arda Biomaterials raises £4m seed led by Oyster Bay Venture Capital to scale barley-based leather alternative
Arda Biomaterials develops leather alternatives made from spent grain waste, producing scalable materials for fashion and automotive use without animal hides or plastics.
More venture news
- 1 Oct 2026
RevnuRevnu secures a £2.3m seed round led by PXN Ventures to help early-stage companies automate growth
SeedMarketing - 24 Sept 2026
IMS SolutionsIMS Solutions raises a £1.1m seed round led by Midlands Mindforge to develop steroid tests for cancer and PMOS
SeedHealth - 23 Sept 2026
OneClickComplyOneClickComply raises £1m seed round led by Mercia Ventures to automate cyber security compliance for businesses
SeedCybersecurity